A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer

NCT00738387 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

900

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: ASA404
DRUG: Placebo
DRUG: docetaxel

Sponsor

Novartis Pharmaceuticals